ID   TIMP3_HUMAN             Reviewed;         211 AA.
AC   P35625; B2RBY9; Q5THV4; Q9UC74; Q9UGS2;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 2.
DT   07-APR-2021, entry version 203.
DE   RecName: Full=Metalloproteinase inhibitor 3;
DE   AltName: Full=Protein MIG-5;
DE   AltName: Full=Tissue inhibitor of metalloproteinases 3;
DE            Short=TIMP-3;
DE   Flags: Precursor;
GN   Name=TIMP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary carcinoma;
RX   PubMed=8174111;
RA   Uria J.A., Ferrando A.A., Velasco G., Freije J.M., Lopez-Otin C.;
RT   "Structure and expression in breast tumors of human TIMP-3, a new member of
RT   the metalloproteinase inhibitor family.";
RL   Cancer Res. 54:2091-2094(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7772252; DOI=10.1089/dna.1994.13.711;
RA   Wilde C.G., Hawkins P.R., Coleman R.T., Levine W.B., Delegeane A.M.,
RA   Okamoto P.M., Ito L.Y., Scott R.W., Seilhamer J.J.;
RT   "Cloning and characterization of human tissue inhibitor of
RT   metalloproteinases-3.";
RL   DNA Cell Biol. 13:711-718(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=8163205; DOI=10.1016/0378-1119(94)90588-6;
RA   Silbiger S.M., Jacobsen V.L., Cupples R.L., Koski R.A.;
RT   "Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue
RT   inhibitor of metalloproteinase family.";
RL   Gene 141:293-297(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8034652;
RA   Wick M., Buerger C., Bruesselbach S., Lucibello F., Mueller R.;
RT   "A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene
RT   family is regulated during G1 progression, mitogenic stimulation,
RT   differentiation, and senescence.";
RL   J. Biol. Chem. 269:18953-18960(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8808469; DOI=10.1101/gr.5.5.483;
RA   Stoehr H., Roomp K., Felbor U., Weber B.H.F.;
RT   "Genomic organization of the human tissue inhibitor of metalloproteinases-3
RT   (TIMP3).";
RL   Genome Res. 5:483-487(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8806658; DOI=10.1006/bbrc.1996.1379;
RA   Ruiz A.C., Brett P., Bok D.;
RT   "TIMP-3 is expressed in the human retinal pigment epithelium.";
RL   Biochem. Biophys. Res. Commun. 226:467-474(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 14-211.
RC   TISSUE=Placenta;
RX   PubMed=8188246; DOI=10.1006/geno.1994.1016;
RA   Apte S.S., Mattei M.-G., Olsen B.R.;
RT   "Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-
RT   3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22.";
RL   Genomics 19:86-90(1994).
RN   [14]
RP   PROTEIN SEQUENCE OF 24-41.
RX   PubMed=7795886; DOI=10.1016/0945-053x(95)90005-5;
RA   Kishnani N.S., Staskus P.W., Yang T.-T., Masiarz F.R., Hawkes S.P.;
RT   "Identification and characterization of human tissue inhibitor of
RT   metalloproteinase-3 and detection of three additional metalloproteinase
RT   inhibitor activities in extracellular matrix.";
RL   Matrix Biol. 14:479-488(1995).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 42-211.
RC   TISSUE=Placenta;
RX   PubMed=8666262; DOI=10.1016/0378-1119(95)00864-0;
RA   Hammani K., Henriet P.M., Silbiger S.M., DeClerck Y.A.;
RT   "Cloning and partial structure of the gene encoding human tissue inhibitor
RT   of metalloproteinases-3.";
RL   Gene 170:287-288(1996).
RN   [16]
RP   INTERACTION WITH EFEMP1.
RX   PubMed=15123717; DOI=10.1074/jbc.m403026200;
RA   Klenotic P.A., Munier F.L., Marmorstein L.Y., Anand-Apte B.;
RT   "Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of
RT   epithelial growth factor-containing fibulin-like extracellular matrix
RT   protein 1 (EFEMP1). Implications for macular degenerations.";
RL   J. Biol. Chem. 279:30469-30473(2004).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 24-144 IN COMPLEX WITH TACE, AND
RP   DISULFIDE BONDS.
RX   PubMed=18638486; DOI=10.1016/j.jmb.2008.06.088;
RA   Wisniewska M., Goettig P., Maskos K., Belouski E., Winters D., Hecht R.,
RA   Black R., Bode W.;
RT   "Structural determinants of the ADAM inhibition by TIMP-3: crystal
RT   structure of the TACE-N-TIMP-3 complex.";
RL   J. Mol. Biol. 381:1307-1319(2008).
RN   [18]
RP   VARIANTS SFD CYS-191 AND CYS-204.
RX   PubMed=7894485; DOI=10.1038/ng1294-352;
RA   Weber B.H.F., Vogt G., Pruett R.C., Stoehr H., Felbor U.;
RT   "Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in
RT   patients with Sorsby's fundus dystrophy.";
RL   Nat. Genet. 8:352-356(1994).
RN   [19]
RP   VARIANT SFD CYS-179.
RX   PubMed=8634721; DOI=10.1093/hmg/4.12.2415;
RA   Felbor U., Stoehr H., Amann T., Schoenherr U., Weber B.H.F.;
RT   "A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3
RT   (TIMP3) in Sorsby's fundus dystrophy with unusual clinical features.";
RL   Hum. Mol. Genet. 4:2415-2416(1995).
RN   [20]
RP   VARIANT SFD CYS-190.
RX   PubMed=7550309; DOI=10.1038/ng0995-27;
RA   Jacobson S.G., Cideciyan A.V., Regunath G., Rodriguez F.J., Vandenburgh K.,
RA   Sheffield V.C., Stone E.M.;
RT   "Night blindness in Sorsby's fundus dystrophy reversed by vitamin A.";
RL   Nat. Genet. 11:27-32(1995).
RN   [21]
RP   VARIANT SFD CYS-191.
RX   PubMed=8728699; DOI=10.1136/jmg.33.3.233;
RA   Felbor U., Stoehr H., Amann T., Schoenherr U., Apfelstedt-Sylla E.,
RA   Weber B.H.F.;
RT   "A second independent Tyr168Cys mutation in the tissue inhibitor of
RT   metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.";
RL   J. Med. Genet. 33:233-236(1996).
RN   [22]
RP   VARIANT SFD CYS-189.
RX   PubMed=8981947;
RA   Felbor U., Suvanto E.A., Forsius H.R., Eriksson A.W., Weber B.H.;
RT   "Autosomal recessive Sorsby fundus dystrophy revisited: molecular evidence
RT   for dominant inheritance.";
RL   Am. J. Hum. Genet. 60:57-62(1997).
CC   -!- FUNCTION: Complexes with metalloproteinases (such as collagenases) and
CC       irreversibly inactivates them by binding to their catalytic zinc
CC       cofactor. May form part of a tissue-specific acute response to
CC       remodeling stimuli. Known to act on MMP-1, MMP-2, MMP-3, MMP-7, MMP-9,
CC       MMP-13, MMP-14 and MMP-15.
CC   -!- SUBUNIT: Interacts with EFEMP1. {ECO:0000269|PubMed:15123717,
CC       ECO:0000269|PubMed:18638486}.
CC   -!- INTERACTION:
CC       P35625; P50052: AGTR2; NbExp=7; IntAct=EBI-1748085, EBI-1748067;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix.
CC   -!- DISEASE: Sorsby fundus dystrophy (SFD) [MIM:136900]: Rare autosomal
CC       dominant macular disorder with an age of onset in the fourth decade. It
CC       is characterized by loss of central vision from subretinal
CC       neovascularization and atrophy of the ocular tissues. Generally,
CC       macular disciform degeneration develops in the patients eye within 6
CC       months to 6 years. {ECO:0000269|PubMed:7550309,
CC       ECO:0000269|PubMed:7894485, ECO:0000269|PubMed:8634721,
CC       ECO:0000269|PubMed:8728699, ECO:0000269|PubMed:8981947}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the protease inhibitor I35 (TIMP) family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Mutations of the TIMP3 gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="https://www.retina-international.org/files/sci-news/timpmut.htm";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X76227; CAA53813.1; -; mRNA.
DR   EMBL; S78453; AAB34532.1; -; mRNA.
DR   EMBL; U14394; AAB60373.1; -; mRNA.
DR   EMBL; U02571; AAA17672.1; -; mRNA.
DR   EMBL; Z30183; CAA82918.1; -; Genomic_DNA.
DR   EMBL; U33114; AAC50393.1; -; Genomic_DNA.
DR   EMBL; U33110; AAC50393.1; JOINED; Genomic_DNA.
DR   EMBL; U33111; AAC50393.1; JOINED; Genomic_DNA.
DR   EMBL; U33112; AAC50393.1; JOINED; Genomic_DNA.
DR   EMBL; U33113; AAC50393.1; JOINED; Genomic_DNA.
DR   EMBL; U67195; AAB07547.1; -; mRNA.
DR   EMBL; CR456593; CAG30479.1; -; mRNA.
DR   EMBL; BT006848; AAP35494.1; -; mRNA.
DR   EMBL; AK314871; BAG37386.1; -; mRNA.
DR   EMBL; AL023282; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z98256; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60038.1; -; Genomic_DNA.
DR   EMBL; BC014277; AAH14277.1; -; mRNA.
DR   EMBL; L15078; AAA21815.1; -; mRNA.
DR   EMBL; U38955; AAB17602.1; -; Genomic_DNA.
DR   EMBL; U38952; AAB17602.1; JOINED; Genomic_DNA.
DR   EMBL; U38953; AAB17602.1; JOINED; Genomic_DNA.
DR   EMBL; U38954; AAB17602.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS13911.1; -.
DR   PIR; S45317; S45317.
DR   RefSeq; NP_000353.1; NM_000362.4.
DR   PDB; 3CKI; X-ray; 2.30 A; B=24-144.
DR   PDBsum; 3CKI; -.
DR   SMR; P35625; -.
DR   BioGRID; 112934; 29.
DR   IntAct; P35625; 22.
DR   MINT; P35625; -.
DR   STRING; 9606.ENSP00000266085; -.
DR   DrugBank; DB05383; Pimagedine.
DR   MEROPS; I35.003; -.
DR   iPTMnet; P35625; -.
DR   PhosphoSitePlus; P35625; -.
DR   BioMuta; TIMP3; -.
DR   DMDM; 730948; -.
DR   jPOST; P35625; -.
DR   MassIVE; P35625; -.
DR   MaxQB; P35625; -.
DR   PaxDb; P35625; -.
DR   PeptideAtlas; P35625; -.
DR   PRIDE; P35625; -.
DR   ProteomicsDB; 55117; -.
DR   Antibodypedia; 11314; 755 antibodies.
DR   DNASU; 7078; -.
DR   Ensembl; ENST00000266085; ENSP00000266085; ENSG00000100234.
DR   GeneID; 7078; -.
DR   KEGG; hsa:7078; -.
DR   UCSC; uc003anb.4; human.
DR   CTD; 7078; -.
DR   DisGeNET; 7078; -.
DR   GeneCards; TIMP3; -.
DR   HGNC; HGNC:11822; TIMP3.
DR   HPA; ENSG00000100234; Tissue enhanced (placenta, retina).
DR   MalaCards; TIMP3; -.
DR   MIM; 136900; phenotype.
DR   MIM; 188826; gene.
DR   neXtProt; NX_P35625; -.
DR   OpenTargets; ENSG00000100234; -.
DR   Orphanet; 59181; Sorsby pseudoinflammatory fundus dystrophy.
DR   PharmGKB; PA36528; -.
DR   VEuPathDB; HostDB:ENSG00000100234.11; -.
DR   eggNOG; KOG4745; Eukaryota.
DR   GeneTree; ENSGT00940000159601; -.
DR   HOGENOM; CLU_084029_0_0_1; -.
DR   InParanoid; P35625; -.
DR   OMA; WYRGMTT; -.
DR   OrthoDB; 1122531at2759; -.
DR   PhylomeDB; P35625; -.
DR   TreeFam; TF317409; -.
DR   PathwayCommons; P35625; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   SIGNOR; P35625; -.
DR   BioGRID-ORCS; 7078; 6 hits in 990 CRISPR screens.
DR   ChiTaRS; TIMP3; human.
DR   EvolutionaryTrace; P35625; -.
DR   GeneWiki; TIMP3; -.
DR   GenomeRNAi; 7078; -.
DR   Pharos; P35625; Tbio.
DR   PRO; PR:P35625; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P35625; protein.
DR   Bgee; ENSG00000100234; Expressed in decidua and 242 other tissues.
DR   Genevisible; P35625; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0031089; C:platelet dense granule lumen; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008191; F:metalloendopeptidase inhibitor activity; IBA:GO_Central.
DR   GO; GO:0002020; F:protease binding; IBA:GO_Central.
DR   GO; GO:0010951; P:negative regulation of endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IMP:BHF-UCL.
DR   GO; GO:0051045; P:negative regulation of membrane protein ectodomain proteolysis; IMP:BHF-UCL.
DR   GO; GO:1904684; P:negative regulation of metalloendopeptidase activity; ISS:BHF-UCL.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:1903984; P:positive regulation of TRAIL-activated apoptotic signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0034097; P:response to cytokine; IBA:GO_Central.
DR   GO; GO:0009725; P:response to hormone; IBA:GO_Central.
DR   GO; GO:0010033; P:response to organic substance; IBA:GO_Central.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   Gene3D; 2.40.50.120; -; 1.
DR   Gene3D; 3.90.370.10; -; 1.
DR   InterPro; IPR001134; Netrin_domain.
DR   InterPro; IPR001820; TIMP.
DR   InterPro; IPR008993; TIMP-like_OB-fold.
DR   InterPro; IPR015612; TIMP3.
DR   InterPro; IPR027465; TIMP_C.
DR   InterPro; IPR030490; TIMP_CS.
DR   PANTHER; PTHR11844; PTHR11844; 1.
DR   PANTHER; PTHR11844:SF22; PTHR11844:SF22; 1.
DR   Pfam; PF00965; TIMP; 1.
DR   SMART; SM00206; NTR; 1.
DR   SUPFAM; SSF50242; SSF50242; 1.
DR   PROSITE; PS50189; NTR; 1.
DR   PROSITE; PS00288; TIMP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disease variant; Disulfide bond;
KW   Extracellular matrix; Metal-binding; Metalloenzyme inhibitor;
KW   Metalloprotease inhibitor; Protease inhibitor; Reference proteome;
KW   Secreted; Sensory transduction; Signal; Vision; Zinc.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000269|PubMed:7795886"
FT   CHAIN           24..211
FT                   /note="Metalloproteinase inhibitor 3"
FT                   /id="PRO_0000034341"
FT   DOMAIN          24..143
FT                   /note="NTR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00295"
FT   REGION          24..27
FT                   /note="Involved in metalloproteinase-binding"
FT                   /evidence="ECO:0000269|PubMed:18638486,
FT                   ECO:0007744|PDB:3CKI"
FT   REGION          88..89
FT                   /note="Involved in metalloproteinase-binding"
FT                   /evidence="ECO:0000269|PubMed:18638486,
FT                   ECO:0007744|PDB:3CKI"
FT   REGION          105..188
FT                   /note="Mediates interaction with EFEMP1"
FT                   /evidence="ECO:0000269|PubMed:15123717"
FT   METAL           24
FT                   /note="Zinc; via amino nitrogen and carbonyl oxygen; shared
FT                   with metalloproteinase partner"
FT                   /evidence="ECO:0000269|PubMed:18638486,
FT                   ECO:0007744|PDB:3CKI"
FT   SITE            85
FT                   /note="Involved in metalloproteinase-binding"
FT                   /evidence="ECO:0000269|PubMed:18638486,
FT                   ECO:0007744|PDB:3CKI"
FT   DISULFID        24..91
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00295,
FT                   ECO:0000269|PubMed:18638486, ECO:0007744|PDB:3CKI"
FT   DISULFID        26..118
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00295,
FT                   ECO:0000269|PubMed:18638486, ECO:0007744|PDB:3CKI"
FT   DISULFID        36..143
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00295,
FT                   ECO:0000269|PubMed:18638486, ECO:0007744|PDB:3CKI"
FT   DISULFID        145..192
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00295"
FT   DISULFID        150..155
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00295"
FT   DISULFID        163..184
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00295"
FT   VARIANT         179
FT                   /note="S -> C (in SFD; dbSNP:rs137853300)"
FT                   /evidence="ECO:0000269|PubMed:8634721"
FT                   /id="VAR_007508"
FT   VARIANT         189
FT                   /note="G -> C (in SFD; dbSNP:rs137853301)"
FT                   /evidence="ECO:0000269|PubMed:8981947"
FT                   /id="VAR_008290"
FT   VARIANT         190
FT                   /note="G -> C (in SFD)"
FT                   /evidence="ECO:0000269|PubMed:7550309"
FT                   /id="VAR_010901"
FT   VARIANT         191
FT                   /note="Y -> C (in SFD; dbSNP:rs137853299)"
FT                   /evidence="ECO:0000269|PubMed:7894485,
FT                   ECO:0000269|PubMed:8728699"
FT                   /id="VAR_007509"
FT   VARIANT         204
FT                   /note="S -> C (in SFD; dbSNP:rs137853298)"
FT                   /evidence="ECO:0000269|PubMed:7894485"
FT                   /id="VAR_007510"
FT   CONFLICT        16..23
FT                   /note="LGDWGAEA -> WGTGAPR (in Ref. 4; CAA82918)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        21..22
FT                   /note="AE -> R (in Ref. 13; AAA21815)"
FT                   /evidence="ECO:0000305"
FT   HELIX           31..37
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   STRAND          39..42
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   STRAND          45..52
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   STRAND          55..57
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   STRAND          59..65
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   STRAND          69..71
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   TURN            73..75
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   STRAND          76..78
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   STRAND          81..86
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   HELIX           88..90
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   STRAND          102..108
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   TURN            124..126
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   HELIX           129..136
FT                   /evidence="ECO:0007744|PDB:3CKI"
FT   TURN            137..140
FT                   /evidence="ECO:0007744|PDB:3CKI"
SQ   SEQUENCE   211 AA;  24145 MW;  15CF831028BABF7A CRC64;
     MTPWLGLIVL LGSWSLGDWG AEACTCSPSH PQDAFCNSDI VIRAKVVGKK LVKEGPFGTL
     VYTIKQMKMY RGFTKMPHVQ YIHTEASESL CGLKLEVNKY QYLLTGRVYD GKMYTGLCNF
     VERWDQLTLS QRKGLNYRYH LGCNCKIKSC YYLPCFVTSK NECLWTDMLS NFGYPGYQSK
     HYACIRQKGG YCSWYRGWAP PDKSIINATD P
//
